H. Takano et al., MONITORING OF HEPATIC VENOUS OXYGEN-SATURATION FOR PREDICTING ACUTE LIVER DYSFUNCTION AFTER FONTAN OPERATIONS, Journal of thoracic and cardiovascular surgery, 108(4), 1994, pp. 700-708
Acute liver dysfunction after Fontan operations may result from inadeq
uate hepatic perfusion along with low cardiac output and high central
venous pressure. We monitored hepatic venous oxygen saturation in 15 p
atients after Fontan operations to determine whether oxygen saturation
predicts the occurrence and severity of acute liver dysfunction. We m
easured oxygen saturation from hepatic venous blood samples every 4 to
5 hours for at least 24 hours after the operation and used the mean h
epatic venous oxygen saturation value for the first 24 hours after the
operation to analyze the relationship between oxygen saturation and h
epatic function. As indices of hepatic function, we measured serum ala
nine aminotransferase, total bilirubin, blood lactate (arterial, hepat
ic venous, and the difference between them), and the arterial ketone b
ody ratio (the ratio of aceto-acetate to P-hydroxybutyrate). For alani
ne aminotransferase and bilirubin, we used the maximal values during t
he first week in the analysis, and for blood lactate and ketone body r
atio, we used the mean values for the first 24 hours after the operati
on. Significant broken-line regression relationships existed between m
ean hepatic venous oxygen saturation and hepatic function indices (ala
nine aminotransferase, total bilirubin, and blood lactate). The interp
retation of these relationships is that hepatic indices are constant a
bove the critical mean hepatic venous oxygen saturation values but are
correlated with mean hepatic venous oxygen saturation below critical
points in the range of 21% to 26%. Thus a hepatic venous oxygen satura
tion value below about 25% during the first 24 hours after a Fontan op
eration predicts the occurrence and the severity of acute liver dysfun
ction. We suggest that monitoring hepatic venous oxygen saturation is
useful for management of critically ill patients after Fontan operatio
ns.